|
Physiomics PLC - Oxfordshire, England-based mathematical modelling for the development of new therapeutics and personalised medicines - Chief Executive Peter Sargent intends to step down on May 29 this year ‘to pursue other opportunities’. Physiomics says the search for a replacement CEO is underway. Notes that Non-Executive Chair Jim Millen will resume the position of executive chair when Sargent departs, for ‘as long as required to ensure business continuity in the event a suitable replacement has not been found by that date.’ Millen was previously the CEO of the company from 2016 to 2024. The company expects to deliver total revenue in line with market expectations and will post its interim results in March, in line with its usual reporting timetable. ‘Following our strategic review in early 2024, the company has made considerable progress on its principal growth initiatives. Pete has played an instrumental role in achieving these objectives, contributing to notable revenue increases and record levels of contract wins over the past two years,’ says Millen. ‘We are excited for the next stage in Physiomics’ growth...with a record level of contracted projects, a new biometrics service-line already generating revenue, and significant progress across our personalised medicine dosing software initiative,’ he continues. Current stock price: 0.30 pence, down 20% on Wednesday afternoon in London 12-month change: down 56% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
